Menu
PNP Therapeutics

The PNP Technology

PNP Patents

PURINE NUCLEOSIDE PHOSPHORYLASE AS ENZYMATIC ACTIVATOR OF NUCLEOSIDE PRODRUGS

UAB Record ID Status Country Application Number Reg. / Grant number
UAB-22002/22 Granted United States of America 13/059,178 8,628,767
UAB-220AUSDIV-tmPNP Granted Australia 20162311630
UAB-22028/22 Granted China 200980140441.9 CN 102186497 B
UAB-22041/22 Pending India 1836/DELNP/2011  
UAB-22043/22 Granted Japan 2011-523217 5567016
UAB-220KORDIV-tmPNP Granted Korea (South) 10-2016-7034607 10-1726282
  Granted Korea (South) 10-20160-147064 10-1726390
UAB-220FRA Granted France EP09807420.6 EP2331115
UAB-220GER Granted Germany 602009032156.0 EP2331115
UAB-220HON Granted Hong Kong 12101387.5 HK1160798
UAB-220ITA Granted Italy 502015000058838 EP2331115
UAB-220SPA Granted Spain EP09807420.6 ES2609685T3
UAB-220UK Granted United Kingdom EP09807420.6 EP2331115

 

 

ENHANCED EFFICACY THERAPY WITH PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG

UAB Record ID Status Country Application Number Reg. / Grant number
UAB-0229EUR Granted European Patent Office (EPO) EP12746580.5 EP2675483
UAB-0229FRA Granted France EP12746580.5 EP2675483
UAB-0229GER Granted Germany EP12746580.5 EP2675483
UAB-0229ITA Granted Italy EP12746580.5 EP2675483
UAB-0229SPA Granted Spain EP12746580.5 EP2675483
UAB-0229UK Granted United Kingdom EP12746580.5 EP2675483
UAB-0229EURDIV Pending European Patent Office (EPO) EP18195237.5  
UAB-229AUS Granted Australia 2012219269 2012219269
UAB-229CAN Pending Canada 2,827,645  
UAB-229CHI Pending China 201710819433.3  
UAB-229IND Pending India 8151/DELNP/2013  
UAB-229JAP Granted Japan 2013-554669 6328427
UAB-229JAPDIV Granted Japan 2018-001159 6650953
UAB-229KOR Granted Korea (South) 10-2013-7024895 10-1969333
UAB-229US Granted United States of America 14/000,367 10,080,784
UAB-229USDIV Pending United States of America 16/100,343